<DOC>
	<DOCNO>NCT00289406</DOCNO>
	<brief_summary>The goal study compare antihypertensive effect tolerability S-amlodipine gentisate amlodipine besylate patient mild moderate hypertension .</brief_summary>
	<brief_title>Efficacy Safety Study S-Amlodipine Gentisate Compared Amlodipine Besylate Treat Mild-to-Moderate Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>patient require mean cuff sit diastolic blood pressure ≥90 ≤109 mmHg successful completion 2week placebo runin period serious disorder could limit ability patient participate study significant cardiovascular disease ( angina , myocardial infarction , cerebrovascular disease , significant arrhythmia precede 6 month ) uncontrolled diabetes mellitus ( serum glucose level ≥140 mg/dl ) insulin dependent diabetes mellitus ( type I ) secondary hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>hypertension</keyword>
</DOC>